Skip to main content

Advertisement

SpringerLink
Log in

Repositioning of dexamethasone intravitreal implant (Ozurdex®) migrated into the anterior chamber

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Ozurdex® (Allergan Inc., Irvine, CA, USA) is a biodegradable implant of dexamethasone (0.7 mg) injected into the vitreous cavity to treat macular oedema. We report a case of migration of Ozurdex® into the anterior chamber in a patient who had a previous iris-claw lens implantation. Surgical removal of the implant was avoided due to the absence of anterior complications and the loss of effectiveness of the drug delivery system. Repositioning of the implant to the posterior segment is described. This case illustrates the efficacy of this technique in cases of migration into the anterior chamber in eyes without corneal decompensation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Pardo D, Francés E, Gallego R, Díaz-Llopis M (2011) Anterior chamber migration of dexamethasone intravitreal implant Ozurdex®. Graefes Arch Clin Exp Ophthalmol. doi:10.1007/s00417-011-1802-x

  2. Bansal R, Bansal P, Kulkarni P, Gupta V, Sharma A, Gupta A (2012) Wandering Ozurdex® implant. J Ophthalmic Inflamm Infect 2:1–5

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Institut Condal d’Oftalmologia, C/Aragó 469 4º 5º, 08013, Barcelona, Spain

    José I. Vela, Jaume Crespí & David Andreu

  2. Department of Ophthalmology, Hospital de la Santa Creu i de Sant Pau, Barcelona, Spain

    José I. Vela & Jaume Crespí

Authors
  1. José I. Vela
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaume Crespí
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Andreu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to José I. Vela.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vela, J.I., Crespí, J. & Andreu, D. Repositioning of dexamethasone intravitreal implant (Ozurdex®) migrated into the anterior chamber. Int Ophthalmol 32, 583–584 (2012). https://doi.org/10.1007/s10792-012-9604-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-012-9604-7

Keywords

Search

Navigation